Suppression of tissue necrosis factor-alpha or hydrogen peroxide-activated primary human T lymphocytes by Ginkgo biloba extract through down-regulation of activator protein-1 signal transduction

Phytomedicine

Volumn 15, Issue 3, 2008, Pages 170-176

  Tsao, Tien Ping ^a   Lai, Jenn Haung ^a   Yang, Shih Ping ^a   Ho, Ling Jun ^a   Liou, Jun Ting ^a   Cheng, Cheng Chung ^a   Cheng, Shu Meng ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Activator protein 1; Ginkgo biloba extract; T lymphocyte; Tissue necrosis factor alpha

Indexed keywords

GINKGO BILOBA EXTRACT; HYDROGEN PEROXIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFECT; DRUG SPECIFICITY; ENZYME ASSAY; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOMODULATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GINKGO BILOBA; HUMANS; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOCYTE ACTIVATION; PLANT EXTRACTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

GINKGO BILOBA;

EID: 39049171165     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.03.016     Document Type: Article

References (31)

1. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., and Forrester J.S. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65 (1990) 297-302
2. Cheng S.M., Yang S.P., Ho L.J., Tsao T.P., and Lai J.H. Down-regulation of c-jun N-terminal kinase-activator protein-1 signaling pathway by Ginkgo biloba extract in human peripheral blood T cells. Biochem. Pharmacol. 66 (2003) 679-689
3. Clausell N., Kalil P., Biolo A., Molossi S., and Azevedo M. Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy. Cardiovasc. Pathol. 8 (1998) 145-151
4. DeFeudis F.V. Ginkgo biloba Extract (Egb 761): Pharmacological Activities and Clinical Applications (1991), Elsevier, Paris
5. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
6. Edwards P., Cendan J.C., Topping D.B., Moldawer L.L., Mackay S., Copeland III F.M., and Lind D.S. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res. 63 (1996) 9-52
7. Galis Z.S., Muszynski M., and Sukhova G.K. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75 (1994) 181-189
8. Gilston V., Williams M.A., Newland A.C., and Winyard P.G. Hydrogen peroxide and tumor necrosis factor-alpha induce NF-kappa B-DNA binding in primary human T lymphocytes in addition to T cell lines. Free Radical Res. 35 (2001) 681-691
9. Jormsjö S., Ye S., Moritz J., Walter D.H., Dimmeler S., Zeiher A.M., Henney A., Hamsten A., and Eriksson P. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ. Res. 86 (2000) 998-1003
10. Jiao Y.B., Rui Y.C., Li T.J., Yang P.Y., and Qiu Y. Expression of pro-inflammatory and anti-inflammatory cytokines in brain of atherosclerotic rats and effects of Ginkgo biloba extracts. Acta Pharmacol. Sin. 26 (2005) 835-839
11. Kadokami T., Frye C., Lemster B., Wagner C.L., Feldman A.M., and McTiernan C.F. Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model. Circulation 104 (2001) 1094-1097
12. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9 (1997) 240-246
13. Koshiyama H., Honjo S., Hamamoto Y., Ikeda H., and Wada Y. Drugs share antidiabetic and antiatherosclerotic actions through the common soil. Med. Hypotheses 66 (2006) 473-475
14. Kressmann S., Müller W.E., and Blume H.H. Pharmaceutical quality of different Ginkgo biloba brands. J. Pharm. Pharmacol. 54 (2002) 661-669
15. Kubota T., Bounoutas G.S., Miyagishima M., Kadokami T., Sanders V.J., Bruton C., Robbins P.D., McTiernan C.F., and Feldman A.M. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101 (2000) 2518-2525
16. Kyriakis J.M. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expression 7 (1999) 217-231
17. Lai J.H., Horvath G., Subleski J., Bruder J., Ghosh P., and Tan T.H. Rel A is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell Biol. 15 (1995) 4260-4271
18. Lai J.H., Ho L.J., Lu K.C., Chang D.M., Shaio M.F., and Han S.H. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 166 (2001) 6914-6924
19. Lin S.J., Yang T.H., Chen Y.H., Chen J.W., Kwok C.F., Shiao M.S., and Chen Y.L. Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1β expression after balloon injury in cholesterol-fed rabbits in vivo. J. Cell. Biochem. 85 (2002) 572-582
20. Lucas A.R., Korol R., and Pepine C.J. Inflammation in Atherosclerosis: some thought about acute coronary syndromes. Circulation 113 (2006) e728-e732
21. Maksimowicz-McKinnon K., Bhatt D.L., and Calabrese L.H. Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers. Curr. Opin. Rheumatol. 16 (2004) 18-24
22. Mihm S., Galter D., and Droge W. Modulation of transcription factor NF-κB activity by intracellular glutathine levels and by variations of the extracellular cysteine supply. FASEB J. 9 (1995) 246-252
23. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1990) 115-126
24. Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol. Therapeut. 94 (2002) 123-135
25. Sarzi-Puttini P., Atzeni F., Doria A., Iaccarino L., and Turiel M. Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus 14 (2005) 780-784
26. Schmidt A., Geigenmuller S., Volker W., and Buddecke E. the antiatherogenic and anti-inflammatory effect of HDL-associated lysosphingolipids operates via Akt→NF-kappa B signaling pathways in human vascular endothelial cells. Basic Res. Cardiol. 101 (2006) 109-116
27. Stoll G., and Bendszus M. Inflammation and Atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37 (2006) 1923-1932
28. Tintut Y., Patel J., Parhami F., and Demer L.L. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the camp pathway. Circulation 102 (2002) 2636-2642
29. Vasan R.S., Sullivan L.M., Roubenoff R., Dinarello C.A., Harris T., Benjamin E.J., Sawyer D.B., Levy D., Wilson P.W., and D'Agostino R.B. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107 (2003) 1486-1491
30. Viedt C., Vogel J., Athanasiou T., Shen W., Orth S.R., Kubler W., and Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 914-920
31. Xanthoudakis S., Miao G.G., and Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. USA 91 (1994) 23-27